Repetitive transcranial magnetic stimulation treats depression by delivering magnetic pulses to targeted brain regions. The standard protocol takes six weeks — one session per day, five days per week, thirty sessions total. Roughly 70% of patients with treatment-resistant depression improve; about a quarter achieve sustained remission. The protocol works, but six weeks of daily hospital visits is a significant barrier. Patients who need the treatment most — those with severe, treatment-resistant depression — are often least able to maintain the schedule.
Published in the Journal of Affective Disorders, UCLA researchers tested an accelerated protocol: five sessions per day for five days — the same total dose compressed into one week instead of six. Symptom relief was comparable to the standard protocol. Some patients who showed no immediate improvement experienced strong gains weeks later, suggesting a delayed neuroplastic response that unfolds after stimulation ends.
The structural insight is about what the spacing in the standard protocol actually contributes. Six weeks of daily sessions was not designed from first principles — it evolved from practical scheduling and early clinical experience. The assumption that spacing matters was never rigorously tested against compression. When it was tested, compression worked equally well, which means the therapeutic mechanism does not depend on inter-session recovery time. The brain does not need a day between pulses to consolidate the effect. The six-week timeline was a logistical artifact that became a clinical assumption — a schedule mistaken for a mechanism.